Evidence map›Paper›PMID 38856912›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Studies on the mechanisms of action of MR33317.

Joachim Neumann, C Hesse, S Yahiaoui, P Dallemagne, C Rochais, B Hofmann, U Gergs

Abstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Prokinetic drugs that stimulate 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joachim NeumannInstitute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Germany. joachim.neumann@medizin.uni-halle.de.
C HesseInstitute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Germany.
S YahiaouiNormandie Univ, UNICAEN CERMN (Centre d'Etudes Et de Recherche Sur Le Médicament de Normandie), 14032, Caen, France.
P DallemagneNormandie Univ, UNICAEN CERMN (Centre d'Etudes Et de Recherche Sur Le Médicament de Normandie), 14032, Caen, France.
C RochaisNormandie Univ, UNICAEN CERMN (Centre d'Etudes Et de Recherche Sur Le Médicament de Normandie), 14032, Caen, France.
B HofmannDepartment of Cardiac Surgery, Mid-German Heart Center, University Hospital Halle, Ernst-Grube Straße 40, 06097, Halle (Saale), Germany.
U GergsInstitute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MR33317 was synthesized as an acetylcholinesterase-inhibitor and an agonist at brain 5-HT

Indexed as

Heart AtriaReceptors, Serotonin, 5-HT4AnimalsCholinesterase InhibitorsHeart RateHumansMaleMiceMice, TransgenicMyocardial ContractionSerotonin 5-HT4 Receptor AgonistsCholinesterase InhibitorsReceptors, Serotonin, 5-HT4Serotonin 5-HT4 Receptor Agonists5-HT4-receptorsHuman atriumMR33317Transgenic mice

Identifiers

PMID38856912
PMCPMC11522085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.